A Novel Nomogram Based on Initial Features to Predict BPH Progression
Open Access
- 8 August 2022
- journal article
- research article
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 19 (15) , 9738
Abstract
Objectives: The aim of this study was to establish a tool to identify patients at risk for pharmaceutical and surgical interventions for benign prostatic hyperplasia (BPH)-related lower urinary tract symptoms (LUTS) over a 10 year follow-up. Methods: The data of patients with mild to moderate male LUTS undergoing phytotherapy from January to December 2010 were reviewed. Patients were followed for 10 years through medical visits and telephone consultations. The outcomes were (1) treatment switch from phytotherapy or no therapy to alpha-blockers or 5α-reductase inhibitors (5-ARI), and (2) clinical progression (acute urinary retention or need for surgery). Two calibrated nomograms (one for each outcome) were constructed on significant predictors at multivariate analysis. Results: A total of 107 patients with a median age of 55 years at presentation were included; 47% stopped or continued phytotherapy, while 53% switched to alpha-blockers and/or 5-ARI after a median time of 24 months. One-third in the second group experienced clinical progression after a median time of 54 months. Age, symptom score, peak flow rate (Qmax), prostate-specific antigen (PSA), and post-void residual volume were significantly associated with the outcomes. According to our nomograms, patients switching therapy or progressing clinically had average scores of 75% and 40% in the dedicated nomograms, respectively, as compared to 25% and 75% and >40% for high risk and <25% and <5% for low risk of pharmaceutical or surgical interventions, respectively, can be proposed.Keywords
This publication has 20 references indexed in Scilit:
- The diagnosis of benign prostatic obstruction: Development of a clinical nomogramNeurourology and Urodynamics, 2014
- Burden of male lower urinary tract symptoms ( LUTS ) suggestive of benign prostatic hyperplasia ( BPH ) – focus on the UKBJU International, 2014
- Baseline characteristics predict risk of progression and response to combined medical therapy for benign prostatic hyperplasia ( BPH )BJU International, 2014
- BPH progression: concept and key learning from MTOPS, ALTESS, COMBAT, and ALF‐ONEBJU International, 2008
- Baseline Factors as Predictors of Clinical Progression of Benign Prostatic Hyperplasia in Men Treated With PlaceboJournal of Urology, 2006
- Definition of at‐risk patients: dynamic variablesBJU International, 2006
- Post-Void Residual Urine Volume is Not a Good Predictor of the Need for Invasive Therapy Among Patients With Benign Prostatic HyperplasiaJournal of Urology, 2006
- The standardisation of terminology of lower urinary tract function: Report from the standardisation sub‐committee of the International Continence SocietyNeurourology and Urodynamics, 2002
- Serum prostate-specific antigen concentration is a powerful predictor of acute urinary retention and need for surgery in men with clinical benign prostatic hyperplasiaUrology, 1999
- Natural history of prostatism: Impact of urinary symptoms on quality of life in 2115 randomly selected community menUrology, 1994